The lawsuits contend that the pharmaceutical company is at fault for the addictions suffered by OxyContin users and is seeking damages from the company. The plaintiffs contend that Purdue marketed OxyContin dishonestly and failed to tell doctors, pharmacists, and patients about the drug's addictive potential.

The individual suits were filed after a Staten Island judge decided not to certify a class-action lawsuit against Purdue. On Friday, 14 cartons of documents were dropped off at a Staten Island courthouse.

Purdue promised to defend the case strongly. "Over the last four years, Purdue Pharma has never lost an OxyContin personal-injury lawsuit," said company spokesperson Timothy Bannon.  "On the contrary, 365 personal-injury lawsuits involving well over 1,000 plaintiffs, including many cases brought by these same personal-injury lawyers, have ended in Purdue's favor. We expect these new cases will be no different."

COMMENTS ON THIS ARTICLE:
(Comments now appear first to last)

Your Turn! Post a public comment (guidelines):

Name:
Comment: (limit 250 words)
Enter this word (help):	Change

GUIDELINES: 
To keep this feature useful for everyone, please:

1. Keep it clean, courteous, brief, and on-topic. Comments are for discussion of the above article, not general rants or manifestos. Serial comments intended to circumvent the 250-word limit may be deleted.
   
   
2. Do not post promotional web links, personal information or requests for assistance (get help).
   
   
3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercial posts are prohibited. We reserve the right to remove comments. (Report a comment).

Have questions or feedback? Contact us.